2021
DOI: 10.1016/j.actbio.2020.11.027
|View full text |Cite
|
Sign up to set email alerts
|

Construction of a pH-responsive, ultralow-dose triptolide nanomedicine for safe rheumatoid arthritis therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 57 publications
(28 citation statements)
references
References 40 publications
1
27
0
Order By: Relevance
“…The use of amphiphilic pH-sensitive galactosyl dextran-retinal (GDR) nanoparticles to encapsulate triptolide may enhance the anti-inflammatory effect of CIA mouse models 14 . The latest results confirmed that by encapsulating triptolide in the star-shaped amphiphilic block copolymer POSS-PCL-b-PDMAEMA, the constructed pH-sensitive triptolide nanomedicine can achieve significant anti-inflammatory effects at ultra-low doses to treat RA 15 . The use of nanomaterials to carry triptolide has many advantages, such as targeted drug delivery and reduced triptolide dose.…”
Section: Biological Functionssupporting
confidence: 58%
“…The use of amphiphilic pH-sensitive galactosyl dextran-retinal (GDR) nanoparticles to encapsulate triptolide may enhance the anti-inflammatory effect of CIA mouse models 14 . The latest results confirmed that by encapsulating triptolide in the star-shaped amphiphilic block copolymer POSS-PCL-b-PDMAEMA, the constructed pH-sensitive triptolide nanomedicine can achieve significant anti-inflammatory effects at ultra-low doses to treat RA 15 . The use of nanomaterials to carry triptolide has many advantages, such as targeted drug delivery and reduced triptolide dose.…”
Section: Biological Functionssupporting
confidence: 58%
“…Triptolide (TP), a diterpene triepoxide isolated from Tripterygium wilfordii Hook F, has been widely used to treat inflammatory and autoimmune diseases, such as systemic lupus erythematosus and RA, but its severe systemic toxicity, especially hepatotoxicity, nephrotoxicity, and cardiotoxicity, along with poor solubility, results in a narrow therapeutic window and poor bioavailability that limit its clinical application (Shen et al., 2019 ; Song et al., 2020 ; Liaw et al., 2021 ; Liu et al., 2021 ). TP has been demonstrated to exhibit anti-inflammatory and immunosuppressive activities, and TP derivatives have been demonstrated to inhibit the polarization of macrophages into the proinflammatory M1 phenotype (Shen et al., 2019 ; Fu et al., 2020 ; Liaw et al., 2021 ; Liu et al., 2021 ). Folic acid (FA)-modified liposomes (FA-Lips) have been demonstrated to have enhanced targeting efficiency by binding to FR with high affinity (Nogueira et al., 2015 ; Xue et al., 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Previously studies have shown the therapeutic potential of TP in animal models of RA [30] . 14 days after building model, the mice were divided into 5 groups (n=6 in each group) at random and the dose of TP is 1mg/kg per body weight, respectively.…”
Section: Pharmacokineticsmentioning
confidence: 99%